{"name":"IGEA","slug":"igea","ticker":"","exchange":"","domain":"","description":"The Interactive Games and Entertainment Association (IGEA) is the industry association for computer and video games in Australia and New Zealand.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Electrochemotherapy","genericName":"Electrochemotherapy","slug":"electrochemotherapy","indication":"Other","status":"discontinued"}]}],"pipeline":[{"name":"Electrochemotherapy","genericName":"Electrochemotherapy","slug":"electrochemotherapy","phase":"discontinued","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOSWxTVFVveWhrYkFGZzNWd2g2cTlWMFlkd2pYbkhxMHo5MjVlS1NsVURXVTFOb1dCRXNoelJNQzZsQ3oyUXFWZ3RoNTdRbDE5Z2tYZ1ZMMzNDUnQ3dm9JYi1RVDFZNm1JTmJucnJwc2ttMkdPbUVaTXhiWmQ3RDVValhvRWRMSElGcVZGbHd6NWlvczZxeVZwUlFmVUdyVjRfdGJSVFhVa293MmtZ?oc=5","date":"2026-03-20","type":"pipeline","source":"Meyka","summary":"IGPH.SW IGEA Pharma (SIX) -25% pre-market 20 Mar 2026: volume spike, volatility likely - Meyka","headline":"IGPH.SW IGEA Pharma (SIX) -25% pre-market 20 Mar 2026: volume spike, volatility likely","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxObmRrNVRjekRtM1Awb0FTZlhuN0ptLXA0S1ZtOWxDZkFVRWIxbUVucEpyUTlRYWREQmd2WWVlbzBaRGNVUmRfWTRVc1JYN0RXd3BKVC1POUpqZFNlalp1SWNrQmtVOWdJMWhlOGxocUdFUmNUNGZnYW0zNVZyZHRtRmE5SjRhSjJjSHdwMmtGT1NVYUpERFdTUGZnSlM2R2JaZW1Z?oc=5","date":"2026-03-17","type":"pipeline","source":"Meyka","summary":"CHF0.0015 intraday drop: IGEA Pharma (IGPH.SW SIX) -25% 17 Mar 2026 2.03M volume - Meyka","headline":"CHF0.0015 intraday drop: IGEA Pharma (IGPH.SW SIX) -25% 17 Mar 2026 2.03M volume","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNUDdFZ2NRaUZUM1Y4OU1UR2g5d09Xamp5QVM3bmplckw4Mks1VkRBUkZLRVJtRjQ3dU9HZ3Y5a2NyaVFvNjllMnYxVFpvSlg3dk1lWko5M3V0OE8xckFVaEQ1MmNIV3ZPYXJDb0RJdFoya2RITm5mS2EwWEliN1RYT0o2eGFWQnFFVUV5RUk5enZrM0dBLW9KcVNsMUpjV2lfSTVB?oc=5","date":"2026-03-13","type":"pipeline","source":"Meyka","summary":"CHF0.0015 trade in IGPH.SW IGEA Pharma (SIX) Mar 2026: Heavy volume, liquidity - Meyka","headline":"CHF0.0015 trade in IGPH.SW IGEA Pharma (SIX) Mar 2026: Heavy volume, liquidity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPcEJFbXNBdlBOZkFKWml3NnNCQVY3cWs3WGxFV2lSWmFZRFBxY18xdUJIaV9CLWI2a05GM0FQa0VNUWQyYWJNcThqTThvRkVua01qX3ZuUFJUQ0dLN2IwMTNGUGpGdFJocjlxVlA4X09DVjZpV05najRzZnZmYWRLajRDR3FPRjFDRVgwMFVqZW5GU0YzY1kwVlBDUkpLUVhBMHB3?oc=5","date":"2026-03-11","type":"pipeline","source":"Meyka","summary":"25% drop IGPH.SW IGEA Pharma (SIX) pre-mkt 11 Mar 2026: CHF0.0015 heavy volume - Meyka","headline":"25% drop IGPH.SW IGEA Pharma (SIX) pre-mkt 11 Mar 2026: CHF0.0015 heavy volume","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNZjAzQmFnUXFxTlQwb0RMUThzaTAtMjNuY284X2lKOEJyVEFaRllhTk1NTzVMSnBjYzdSVFIteWZSU0JuUXUzTFFjNHBKcFV4RTQ2Z3ZFakJReVU1aHhhazh1Q3JWQU5Ya2ZPZWdJeUdDSm92Si1KdnN5SHJrM0U2VEptYzVIakpYdm9zSk5DSzBTcklPOVh3YUYySTg1ZWdaTnVCczFJTmVTSnc?oc=5","date":"2026-01-13","type":"pipeline","source":"Meyka","summary":"IGPH.SW stock down 25% intraday on SIX 13 Jan 2026: volume signals liquidity risk - Meyka","headline":"IGPH.SW stock down 25% intraday on SIX 13 Jan 2026: volume signals liquidity risk","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOejdPdWJLUkxTYjJGZHJQNmMyOGFtdHZZMzJGZ3NSaGtkc0R0LV9RNDNZMER6NExGYkVqNDdTTXJyTzBFYk1QOWlKalFsbUlOX0luMUVwdjVXak0xLWJUZnJIZGo1N3RIS04zaUxaV1NPY0VEWTBUYjZ1ZU9DTkt2d3JmZXRkUTdIankyamlDZTlabVVkaGNIb1JwdllFM2pPQUE?oc=5","date":"2026-01-09","type":"pipeline","source":"Meyka","summary":"IGPH.SW stock: CHF 0.0015 close on 09 Jan 2026 with heavy volume, what next - Meyka","headline":"IGPH.SW stock: CHF 0.0015 close on 09 Jan 2026 with heavy volume, what next","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOaVM4UVVCVnlGMTdLRHpYSGltN2NaenJWazB4Q3B3ZGRHSi1JQUN6Z25nUUFKTlowdXZwRlQ4SFE2NWFDM0tIdExCRzhSWF9hMnZPampJWEVFZWdSU1JYWjRPZThLNTNZUkp0MkhKR2xRelRWQjh2SUxSdFdwVmJiQWxzbzFXeVdEYkRZRDJBUWpJY1FLWW9OR2lqNWRsUQ?oc=5","date":"2023-06-14","type":"pipeline","source":"EU-Startups","summary":"74 Top Biotechnology Startups and Companies in The Netherlands (2021) - EU-Startups","headline":"74 Top Biotechnology Startups and Companies in The Netherlands (2021) - EU","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNdTBEenlFTE8xWkdKYnFwX2Z6Z3NVdWFvMURNZzdUV0N1R0Q4N0lQeW5wUHM0bnRsWk1laS1nTFFEcDBsR1NFbUJSemExb0pZM3dqalhVbXhneVE0Y3BTemtUVFhwZnN4WDNUdDhNbEo5d0J3Y2EtbkFHZDFaOHNmWi01NlhaN3RTVDQxMXZMSXpnanRBb0ZkVWhBWQ?oc=5","date":"2021-06-14","type":"pipeline","source":"EU-Startups","summary":"87 Top Health Care Startups and Companies in The Netherlands (2021) - EU-Startups","headline":"87 Top Health Care Startups and Companies in The Netherlands (2021) - EU","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5AFBVV95cUxPaDJKek9NMVhabnlJZTBEQVJRMUVOVlZ1Qk9BOXF0NFg2RVRkRDBlQmExMjdOdGRLU3pXSTFqNVhVTkxCLWg2djFzazBoQ09jeElPdVVqdW5Kbno4SUpscUx0MzhSOC1WcE1mTmtTN0diWUxmVlFSN2lzMnQ1OWxWd1dYYk02TW1UQ0FIdWdhLVJKSUFfUFJWWlRJLURJOTljalVSRTJXa3YyLVZYV2tmUV9yMjhteE5OSElYaGtOYlo4RWVveU54MGNuandDUmFNMk0zOTN4dUttdWNXN3h1cG96MDk?oc=5","date":"2021-01-22","type":"trial","source":"Applied Clinical Trials","summary":"Rate of Patient Recruitment to International Multicenter Clinical Studies in Eastern Europe Countries - Applied Clinical Trials","headline":"Rate of Patient Recruitment to International Multicenter Clinical Studies in Eastern Europe Countries","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxPVHR4eURfUDBMOG9vNGtVTGZJWS1lV09jV1JvMTRNN1VicE9hS1FXZkNka0pUYkFNU3dvU2JnTzVRNkhnNmw1dG5vM3RDQmhhX241WWxGRHlJMnZudEZRZTJUSG5HZEcxYUJKcmtEQlZ1dzNIU2lOejJ6blRHOW5FTjF0d2xNM2gzVEJtZVhTNG84UzdFWmc?oc=5","date":"2018-09-26","type":"pipeline","source":"Pharmaceutical Technology","summary":"Top Ten Clinical Research Organisations in the World: Leaders in Medical Research - Pharmaceutical Technology","headline":"Top Ten Clinical Research Organisations in the World: Leaders in Medical Research","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"discontinued":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}